When, if at all, do you use nasolacrimal duct stents to prevent stenosis/obstruction when treating skin, sinonasal, or other mid-facial H&N cancers with radiation therapy?

Topics: Head and Neck Cancers • Radiation Oncology

If so, what is your selection criteria? How long do they remain in place?

Do you have any dose constraints to the nasolacrimal duct?

Answer from: Radiation Oncologist at Academic Institution

I don’t because when the stent is removed, the duct stenoses.

Related Questions